Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D End

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1978
7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serotonin uptakeR A Glennon, B Martin, K M Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1980
Induction of ornithine decarboxylase by renin-free nerve growth factorG Guroff, P Montgomery, N Tolson, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdownR De Coster, W Wouters, R Van Ginckel, et al.
Clinical Pharmacology and Therapeutics|February 25, 2009
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humansM Liem-Moolenaar, D Cerneus, C J Molloy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancerL R Kelland, V Smith, M Valenti, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1978
7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serotonin uptakeR A Glennon, B Martin, K M Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1980
Induction of ornithine decarboxylase by renin-free nerve growth factorG Guroff, P Montgomery, N Tolson, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdownR De Coster, W Wouters, R Van Ginckel, et al.
Clinical Pharmacology and Therapeutics|February 25, 2009
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humansM Liem-Moolenaar, D Cerneus, C J Molloy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancerL R Kelland, V Smith, M Valenti, et al.
Pageof 2